FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000967181> ?p ?o ?g. }

• W2000967181 endingPage "107" @default.
• W2000967181 startingPage "102" @default.
• W2000967181 abstract "Abstract: Antiviral compounds including ganciclovir, foscarnet, and cidofovir are routinely used in the treatment of cytomegalovirus (CMV) infection and disease; however, these agents have a poor oral bioavailability and have the inconvenience and expense of intravenous administration. Aim of the study. To evaluate the safety and efficacy of oral valganciclovir (VGCV) for preemptive treatment of CMV reactivation in the setting of allogeneic hematopoietic stem cell transplantation (HSCT). Patients and methods. We treated 15 patients receiving allogeneic HSCT from related ( n =9) or unrelated ( n =6) donors. In all patients, either the donor, host, or both were CMV Ig G positive pretransplant. Indication for therapy was preemptive treatment of CMV infection defined as one or two consecutive positive tests of pp65 antigenemia assay or CMV‐polymerase chain reaction (PCR). VGCV was administered orally in a dosage of 900 mg b.i.d. for 2 weeks, followed by 450 mg b.i.d. for 2 additional weeks. Results. Patients developed a positive CMV‐PCR after a median of 52 days (range 37–427) post HSCT and a positive pp65 antigenemia after a median time of 74 days (range 37–427) post HSCT. Preemptive treatment with VGCV was started a median time of 56 days (range 37–429) after transplant. In all, 11 patients (73%) completed the 28 days of therapy with VGCV. All patients showed a complete clearance of the virus. The median time to achieve a negative CMV‐PCR was 6 days (range 4–18). A relapse of CMV infection after VGCV preemptive therapy occurred in 6 patients (40%). No patient developed early or late CMV disease. Six patients (40%) presented hematological toxicity including neutropenia and/or thrombocytopenia that required drug discontinuation in 4 cases. Conclusion. VGCV administered as preemptive therapy for CMV infection in patients receiving an allogeneic HSCT showed promise for treating this frequent complication. Prospective randomized studies in this setting are mandatory to yield more definitive results." @default.
• W2000967181 created "2016-06-24" @default.
• W2000967181 creator A5006735476 @default.
• W2000967181 creator A5012551804 @default.
• W2000967181 creator A5013370793 @default.
• W2000967181 creator A5022712318 @default.
• W2000967181 creator A5037132693 @default.
• W2000967181 creator A5040794664 @default.
• W2000967181 creator A5051164378 @default.
• W2000967181 creator A5090040304 @default.
• W2000967181 date "2007-01-30" @default.
• W2000967181 modified "2023-10-12" @default.
• W2000967181 title "Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation" @default.
• W2000967181 cites W1974796184 @default.
• W2000967181 cites W1982618108 @default.
• W2000967181 cites W1985584265 @default.
• W2000967181 cites W1985591067 @default.
• W2000967181 cites W1996791121 @default.
• W2000967181 cites W2040862465 @default.
• W2000967181 cites W2047636084 @default.
• W2000967181 cites W2059471557 @default.
• W2000967181 cites W2061974719 @default.
• W2000967181 cites W2124239845 @default.
• W2000967181 cites W2334092403 @default.
• W2000967181 cites W2547115861 @default.
• W2000967181 doi "https://doi.org/10.1111/j.1399-3062.2006.00183.x" @default.
• W2000967181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17461994" @default.
• W2000967181 hasPublicationYear "2007" @default.
• W2000967181 type Work @default.
• W2000967181 sameAs 2000967181 @default.
• W2000967181 citedByCount "60" @default.
• W2000967181 countsByYear W20009671812012 @default.
• W2000967181 countsByYear W20009671812013 @default.
• W2000967181 countsByYear W20009671812014 @default.
• W2000967181 countsByYear W20009671812015 @default.
• W2000967181 countsByYear W20009671812016 @default.
• W2000967181 countsByYear W20009671812017 @default.
• W2000967181 countsByYear W20009671812019 @default.
• W2000967181 countsByYear W20009671812020 @default.
• W2000967181 countsByYear W20009671812021 @default.
• W2000967181 countsByYear W20009671812022 @default.
• W2000967181 countsByYear W20009671812023 @default.
• W2000967181 crossrefType "journal-article" @default.
• W2000967181 hasAuthorship W2000967181A5006735476 @default.
• W2000967181 hasAuthorship W2000967181A5012551804 @default.
• W2000967181 hasAuthorship W2000967181A5013370793 @default.
• W2000967181 hasAuthorship W2000967181A5022712318 @default.
• W2000967181 hasAuthorship W2000967181A5037132693 @default.
• W2000967181 hasAuthorship W2000967181A5040794664 @default.
• W2000967181 hasAuthorship W2000967181A5051164378 @default.
• W2000967181 hasAuthorship W2000967181A5090040304 @default.
• W2000967181 hasConcept C126322002 @default.
• W2000967181 hasConcept C203014093 @default.
• W2000967181 hasConcept C2522874641 @default.
• W2000967181 hasConcept C2776317777 @default.
• W2000967181 hasConcept C2776409557 @default.
• W2000967181 hasConcept C2776724271 @default.
• W2000967181 hasConcept C2776824251 @default.
• W2000967181 hasConcept C2777408962 @default.
• W2000967181 hasConcept C2777732132 @default.
• W2000967181 hasConcept C2777965375 @default.
• W2000967181 hasConcept C2779820661 @default.
• W2000967181 hasConcept C2780727368 @default.
• W2000967181 hasConcept C2911091166 @default.
• W2000967181 hasConcept C71924100 @default.
• W2000967181 hasConcept C90924648 @default.
• W2000967181 hasConceptScore W2000967181C126322002 @default.
• W2000967181 hasConceptScore W2000967181C203014093 @default.
• W2000967181 hasConceptScore W2000967181C2522874641 @default.
• W2000967181 hasConceptScore W2000967181C2776317777 @default.
• W2000967181 hasConceptScore W2000967181C2776409557 @default.
• W2000967181 hasConceptScore W2000967181C2776724271 @default.
• W2000967181 hasConceptScore W2000967181C2776824251 @default.
• W2000967181 hasConceptScore W2000967181C2777408962 @default.
• W2000967181 hasConceptScore W2000967181C2777732132 @default.
• W2000967181 hasConceptScore W2000967181C2777965375 @default.
• W2000967181 hasConceptScore W2000967181C2779820661 @default.
• W2000967181 hasConceptScore W2000967181C2780727368 @default.
• W2000967181 hasConceptScore W2000967181C2911091166 @default.
• W2000967181 hasConceptScore W2000967181C71924100 @default.
• W2000967181 hasConceptScore W2000967181C90924648 @default.
• W2000967181 hasIssue "2" @default.
• W2000967181 hasLocation W20009671811 @default.
• W2000967181 hasLocation W20009671812 @default.
• W2000967181 hasOpenAccess W2000967181 @default.
• W2000967181 hasPrimaryLocation W20009671811 @default.
• W2000967181 hasRelatedWork W1979471217 @default.
• W2000967181 hasRelatedWork W2075855379 @default.
• W2000967181 hasRelatedWork W2124754010 @default.
• W2000967181 hasRelatedWork W2150793976 @default.
• W2000967181 hasRelatedWork W2286967479 @default.
• W2000967181 hasRelatedWork W2410417504 @default.
• W2000967181 hasRelatedWork W2418784502 @default.
• W2000967181 hasRelatedWork W2418905325 @default.
• W2000967181 hasRelatedWork W4210416713 @default.
• W2000967181 hasRelatedWork W4309728634 @default.
• W2000967181 hasVolume "9" @default.
• W2000967181 isParatext "false" @default.

• next